-
2
-
-
0028301752
-
-
Ross, J. F.; Chaudhuri, P. K.; Ratnam, M. Cancer 1994, 73, 2432.
-
(1994)
Cancer
, vol.73
, pp. 2432
-
-
Ross, J.F.1
Chaudhuri, P.K.2
Ratnam, M.3
-
3
-
-
0026752798
-
-
Weitman, S. D.; Lark, R. H.; Coney, L. R.; Fort, D. W.; Frasca, V.; Zurawski, V. R., Jr; Kamen, B. A. Cancer Res. 1992, 52, 3396.
-
(1992)
Cancer Res.
, vol.52
, pp. 3396
-
-
Weitman, S.D.1
Lark, R.H.2
Coney, L.R.3
Fort, D.W.4
Frasca, V.5
Zurawski Jr., V.R.6
Kamen, B.A.7
-
8
-
-
0347224284
-
-
Ke, C. Y.; Mathias, C. J.; Green, M. A. Nucl. Med. Biol. 2003, 30, 811.
-
(2003)
Nucl. Med. Biol.
, vol.30
, pp. 811
-
-
Ke, C.Y.1
Mathias, C.J.2
Green, M.A.3
-
9
-
-
16544383488
-
-
Ke, C. Y.; Mathias, C. J.; Green, M. A. Adv. Drug Delivery Rev. 2004, 56, 1143.
-
(2004)
Adv. Drug Delivery Rev.
, vol.56
, pp. 1143
-
-
Ke, C.Y.1
Mathias, C.J.2
Green, M.A.3
-
10
-
-
0033378420
-
-
Leamon, C. P.; DePrince, R. B.; Hendren, R. W. J. Drug Target 1999, 7, 157.
-
(1999)
J. Drug Target
, vol.7
, pp. 157
-
-
Leamon, C.P.1
DePrince, R.B.2
Hendren, R.W.3
-
11
-
-
0038116522
-
-
Leamon, C. P.; Cooper, S. R.; Hardee, G. E. Bioconjugate Chem. 2003, 14, 738.
-
(2003)
Bioconjugate Chem.
, vol.14
, pp. 738
-
-
Leamon, C.P.1
Cooper, S.R.2
Hardee, G.E.3
-
12
-
-
19744373251
-
-
Ke, C. Y.; Mathias, C. J.; Green, M. A. J. Am. Chem. Soc. 2005, 127, 7421.
-
(2005)
J. Am. Chem. Soc.
, vol.127
, pp. 7421
-
-
Ke, C.Y.1
Mathias, C.J.2
Green, M.A.3
-
13
-
-
11844282187
-
-
Müller, C.; Dumas, C.; Hoffmann, U.; Schubiger, P. A.; Schibli, R. J. Organomet. Chem. 2004, 689, 4712.
-
(2004)
Organomet. Chem.
, vol.689
, pp. 4712
-
-
Müller, C.1
Dumas, C.2
Hoffmann, U.3
Schubiger, P.A.4
Schibli, R.J.5
-
14
-
-
33646938117
-
-
Müller, C.; Hohn, A.; Schubiger, P. A.; Schibli, R. Eur. J. Nucl. Med. Mol. Imaging 2006, 33, 1007.
-
(2006)
Eur. J. Nucl. Med. Mol. Imaging
, vol.33
, pp. 1007
-
-
Müller, C.1
Hohn, A.2
Schubiger, P.A.3
Schibli, R.4
-
15
-
-
33747135111
-
-
Bettio, A.; Honer, M.; Mueller, C.; Bruehlmeier, M.; Mueller, U.; Schibli, R.; Groehn, V.; Schubiger, P. A.; Ametamey, S. M. J. Nucl. Med. 2006, 47, 1153.
-
(2006)
J. Nucl. Med.
, vol.47
, pp. 1153
-
-
Bettio, A.1
Honer, M.2
Mueller, C.3
Bruehlmeier, M.4
Mueller, U.5
Schibli, R.6
Groehn, V.7
Schubiger, P.A.8
Ametamey, S.M.9
-
16
-
-
0033625094
-
-
Mathias, C. J.; Hubers, D.; Low, P. S.; Green, M. A. Bioconjugate Chem. 2000, 11, 253.
-
(2000)
Bioconjugate Chem.
, vol.11
, pp. 253
-
-
Mathias, C.J.1
Hubers, D.2
Low, P.S.3
Green, M.A.4
-
17
-
-
58149102204
-
-
Ross, T. L.; Honer, M.; Lam, P. Y. H.; Mindt, T. L.; Groehn, V.; Schibli, R.; Schubiger, P. A.; Ametamey, S. M. Bioconjugate Chem. 2008, 19, 2462.
-
(2008)
Bioconjugate Chem.
, vol.19
, pp. 2462
-
-
Ross, T.L.1
Honer, M.2
Lam, P.Y.H.3
Mindt, T.L.4
Groehn, V.5
Schibli, R.6
Schubiger, P.A.7
Ametamey, S.M.8
-
18
-
-
50249092703
-
-
Mindt, T. L.; Müller, C.; Melis, M.; de Jong, M.; Schibli, R. Bioconjugate Chem. 2008, 19, 1689.
-
(2008)
Bioconjugate Chem.
, vol.19
, pp. 1689
-
-
Mindt, T.L.1
Müller, C.2
Melis, M.3
De Jong, M.4
Schibli, R.5
-
19
-
-
0032588840
-
-
Guo, W.; Hinkle, G. H.; Lee, R. J. J. Nucl. Med. 1999, 40, 1563.
-
(1999)
J. Nucl. Med.
, vol.40
, pp. 1563
-
-
Guo, W.1
Hinkle, G.H.2
Lee, R.J.3
-
20
-
-
0030662090
-
-
Luo, J.; Smith, M. D.; Lantrip, D. A.; Wang, S.; Fuchs, P. L. J. Am. Chem. Soc. 1997, 119, 10004.
-
(1997)
J. Am. Chem. Soc.
, vol.119
, pp. 10004
-
-
Luo, J.1
Smith, M.D.2
Lantrip, D.A.3
Wang, S.4
Fuchs, P.L.5
-
21
-
-
79952486899
-
-
4: 441.2, found 441.3
-
4: 441.2, found 441.3.
-
-
-
-
22
-
-
0033200302
-
-
Harris, T. D.; Sworin, M.; Williams, N.; Rajopadhye, M.; Damphousse, P. R.; Glowacka, D.; Poirier, M. J.; Yu, K. Bioconjugate Chem. 1999, 10, 808.
-
(1999)
Bioconjugate Chem.
, vol.10
, pp. 808
-
-
Harris, T.D.1
Sworin, M.2
Williams, N.3
Rajopadhye, M.4
Damphousse, P.R.5
Glowacka, D.6
Poirier, M.J.7
Yu, K.8
-
23
-
-
79952485010
-
-
5 707.3166; found 707.3187
-
5 707.3166; found 707.3187.
-
-
-
-
24
-
-
79952488153
-
-
3OH(B) mixtures were used as the mobile phase (0-10 min, B: 5-50%; 10-20 min, B: 50-50%; 20-25 min, B: 50-5%)
-
3OH(B) mixtures were used as the mobile phase (0-10 min, B: 5-50%; 10-20 min, B: 50-50%; 20-25 min, B: 50-5%).
-
-
-
-
25
-
-
79952490052
-
-
note
-
99mTc complex was assessed by washing the cells with 1 ml of acidic buffer (aqueous solution of 0.1 Macetic acid and 0.15 M NaCl, pH = 3). Finally, the cells were lysed by treatment with 1 ml of 1 N NaOH for 5 min. All the samples were counted for radioactivity using a γ-counter. Cellular protein was determined by using BCA protein assay reagent. The cell binding fractions and cell internalized fractions were calculated per 0.5 mg protein and expressed in relation to the total added activity (% per 0.5 mg protein of total added activity).
-
-
-
-
26
-
-
67349088706
-
-
Müller, C.; Mindt, T. L.; de Jong, M.; Schibli, R. Eur. J. Nucl. Med. Mol. Imaging 2009, 36, 938.
-
(2009)
Eur. J. Nucl. Med. Mol. Imaging
, vol.36
, pp. 938
-
-
Müller, C.1
Mindt, T.L.2
De Jong, M.3
Schibli, R.4
-
27
-
-
79952485043
-
-
3 were used for biodistribution studies
-
3 were used for biodistribution studies.
-
-
-
-
28
-
-
4243513702
-
-
Selhub, J.; Emmanouel, D.; Stavropoulos, T.; Arnold, R. Am. J. Physiol. 1987, 252, F750.
-
(1987)
Am. J. Physiol.
, vol.252
-
-
Selhub, J.1
Emmanouel, D.2
Stavropoulos, T.3
Arnold, R.4
-
30
-
-
33846413546
-
-
Liu, L. Q.; Wang, S. Z.; Li, F.; Teng, B.; Wang, K. Z.; Qiu, F. C. Acta Acad. Med. Sin. 2006, 28, 786.
-
(2006)
Acta Acad. Med. Sin.
, vol.28
, pp. 786
-
-
Liu, L.Q.1
Wang, S.Z.2
Li, F.3
Teng, B.4
Wang, K.Z.5
Qiu, F.C.6
|